April 24, 2020 / 8:06 AM / a month ago

Japanese drug firm Takeda to sell some assets in Europe to Orifarm

TOKYO (Reuters) - Takeda Pharmaceutical Co (4502.T) said it would sell selected over-the-counter (OTC) and prescription pharmaceutical products that are sold in Europe to Orifarm Group.

The sale, which includes two manufacturing sites in Denmark and Poland, would amount to about $670 million subject to customary legal and regulatory closing conditions, Takeda said.

Reporting by Rocky Swift; Editing by Edmund Blair

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below